Value Sense
ISRG
Intuitive Surgical, Inc. (ISRG)
Last Price$567.0(1.1%)
Market Cap$207.3B
Intrinsic value score
7/10
Good
Intrinsic value
$106.1
DCF value - $47.1 Relative value - $165.1
Overvalued
81.3%
LTM P/E
89.3x
Peer set median 26.9x
Discount rate
10.5%
ISRG
is 81.3% overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

ISRG Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 ISRG Relative Value is $169.7, which is overvalued by 70.1%, compared to current share price of $567.0.
DCF Value vs Current Share Price
As of Mar 03, 2025 ISRG DCF Value is $47.9, which is overvalued by 91.5%, compared to current share price of $567.0.
Methodology
Price per share, $
ISRG
Intrinsic value$106.1
Overvalued by81.3%
Current share price
567.0
Relative value
169.7
DCF value
47.9

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

ISRG Historical Intrinsic Value

Crunching data... Almost there!

ISRG vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc.ISRG
(81.3%)
17.2%
27.7%
27.8%
Median Peer Set
1.7%
15.9%
10.2%
Repligen Corporation logo
Repligen CorporationRGEN
(80.8%)
(21.1%)
(80.9%)
5.6%
West Pharmaceutical Services, Inc. logo
West Pharmaceutical Services, Inc.WST
(33.0%)
(1.9%)
(15.5%)
17.0%
Masimo Corporation logo
Masimo CorporationMASI
(26.6%)
0.6%
(42.5%)
4.0%
ResMed Inc. logo
ResMed Inc.RMD
(18.2%)
10.9%
13.4%
21.8%
Alcon Inc. logo
Alcon Inc.ALC
(13.6%)
8.5%
182.9%
10.3%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.2%
8.4%
32.2%
10.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
15.0%
4.2%
18.3%
8.4%
AptarGroup, Inc. logo
AptarGroup, Inc.ATR
19.0%
2.7%
30.2%
10.5%
Baxter International Inc. logo
Baxter International Inc.BAX
51.1%
(69.5%)
(100.0%)
(6.9%)
Hologic, Inc. logo
Hologic, Inc.HOLX
108.2%
(0.0%)
81.1%
19.6%

Explore more intrinsic value tools hub for ISRG

Peter Lynch Fair Value
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
Earnings growth model
DCF value calculator
Discount rate
Peter Lynch charts
Reverse DCF
Relative Value

FAQ

What is Intuitive Surgical, Inc. intrinsic value?

As of Mar 03, 2025, Intuitive Surgical, Inc. Intrinsic Value is $106.1. This suggests it may be overvalued by 81.3% compared to its current price of around $567.0.

What is Intuitive Surgical, Inc. DCF (discounted cash flow) valuation?

As of Mar 03, 2025, Intuitive Surgical, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $47.9. This suggests it may be overvalued by 91.5% to its current price of around $567.0, using a discount rate of 10.5% and terminal growth rate of 3.0%.

Is Intuitive Surgical, Inc. overvalued or undervalued?

Intuitive Surgical, Inc. is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $106.1, compared to a market price of around $567.0. This suggests a potential overvaluation of 81.3%.